2341 GMT - Cochlear's new bull at Citi sees no cause for concern in slowing sales at the hearing-implant maker. Raising his recommendation to buy from neutral, analyst Mathieu Chevrier tells clients in a note that the company is simply seeing the usual slowdown in sales ahead of the launch of its next sound processor model. He isn't worried that the economics of processor upgrades are changing. Chevrier contends that the stock's current valuation at 36 times fiscal 2026 earnings, compared with a historical average of 39, offers a good entry point. Citi lifts its target price 3.4% to A$300.00. Shares are up 1.4% at A$266.98. (stuart.condie@wsj.com)
(END) Dow Jones Newswires
March 05, 2025 18:41 ET (23:41 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。